Plasmid AMEP

Gene therapyexperimental

Clinical trial activity

3 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Jul 1, 2010 (NCT01045915)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetImmunity, active

    tumor antigen

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • plasmid amep

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01664273Phase 1Jul 1, 2012University of Copenhagen
NCT01764009Phase 1/Phase 2 (Phase 2)Jun 1, 2012Valerio
NCT01045915Phase 1Jul 1, 2010Valerio
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
ValerioFor profit2222010
University of CopenhagenAcademic/Hospital1112012
2 organizations
Page 1 / 1